A new methodology for the characterization of synthetic oligonucleotides has been developed by researchers from the University of Tübingen, Germany.
Photo Credit: stock.adobe.com.nobeastsofierce
A new methodology for the characterization of synthetic oligonucleotides has been developed by researchers from the University of Tübingen, Germany (1).
Synthetic oligonucleotides are a class of synthetic nucleic acids, which are generally 12–30 nucleotides in length. They have gained considerable popularity as a therapeutic tool and are a promising product for the regulation of gene expression. As they are to be used in humans and in clinical trials, their production must lead to high purity products. However, a number of issues can arise during their synthesis, such as deleted or extended base sequences or base modifications, and therefore the purification methods and assays for their quality control must be robust and thorough.
The dominant method currently uses ion-pair reversed-phase chromatography with triethylammonium acetate as an ion-pairing agent because oligonucleotides are poorly retained by common reverse-phase liquid chromatography (LC). However, as this method is hyphenated to mass spectrometry some drawbacks occur, such as ion-suppression in electrospray ionization. As such a methodology with sufficient selectivity and better compatibility for MS detection is desirable.
Towards this end, researchers developed a multiple heart-cutting (MHC) two-dimensional liquid chromatography (2D-LC) method with ultra-violet (UV) and electrospray ionization (ESI) mass spectrometry (MS) detection. The first dimension features a reversed-phase/weak anion-exchange (RP/WAX) stationary phase which provides the selectivity required to separate structurally similar oligonucleotide sequences. The second dimension reversed-phase column desalts via a diverter valve, and the active solvent modulation enables the oligonucleotide peak to be viewed without interference from non-volatile buffer components and ion-pair agents, which allows oligonucleotides to be detected in MS-compatible conditions.
Α α, Β β, Γ γ, Δ δ, Ε ε, Ζ ζ, Η η, Θ θ, Ι ι, Κ κ, Λ λ, Μ μ, Ν ν, Ξ ξ, Ο ο, Π π, Ρ ρ, Σ σ/ς, Τ τ, Υ υ, Φ φ, Χ χ, Ψ ψ, Ω ω
Reference
F. Li et al., J. Chroma. A. 1625, 461338 (2020).
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.